These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6383209)

  • 1. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.
    Mack DG; McLeod R
    Antimicrob Agents Chemother; 1984 Jul; 26(1):26-30. PubMed ID: 6383209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S; Pudney M; Derouin F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
    Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assessment of antimicrobial agents against Toxoplasma gondii.
    Harris C; Salgo MP; Tanowitz HB; Wittner M
    J Infect Dis; 1988 Jan; 157(1):14-22. PubMed ID: 3121760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondii.
    Schoondermark-van de Ven E; Vree T; Melchers W; Camps W; Galama J
    Antimicrob Agents Chemother; 1995 Mar; 39(3):763-5. PubMed ID: 7793889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.
    Meneceur P; Bouldouyre MA; Aubert D; Villena I; Menotti J; Sauvage V; Garin JF; Derouin F
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1269-77. PubMed ID: 18212105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
    Khan AA; Lambert LH; Remington JS; Araujo FG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-toxoplasma activities of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro.
    Derouin F; Santillana-Hayat M
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2575-7. PubMed ID: 10952623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
    Wang JL; Elsheikha HM; Li TT; He JJ; Bai MJ; Liang QL; Zhu XQ; Cong W
    Int J Antimicrob Agents; 2019 Dec; 54(6):814-819. PubMed ID: 31479744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.
    Sheffield HG; Melton ML
    J Parasitol; 1975 Aug; 61(4):704-12. PubMed ID: 1165554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.
    Blais J; Tardif C; Chamberland S
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2571-7. PubMed ID: 7509143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
    Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
    J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture.
    Derouin F; Chastang C
    Antimicrob Agents Chemother; 1988 Mar; 32(3):303-7. PubMed ID: 3284458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
    de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
    Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of folate inhibitors on Toxoplasma gondii.
    Derouin F; Chastang C
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1753-9. PubMed ID: 2531568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
    Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.